Access cutting-edge celiac disease treatment through this clinical trial at a research site in Colorado Springs. Study-provided care at no cost to qualified participants.
Access celiac disease specialists in Colorado Springs at no cost
This study follows strict safety protocols and ethical guidelines
All study-related celiac disease treatment provided free
The primary efficacy objective of the trial is to assess the ability of TEV-53408 to attenuate gluten-induced enteropathy in adults with celiac disease. The primary safety objective of the trial is to assess the safety of TEV-53408 in adults with celiac disease. A secondary objective is to further assess the efficacy of TEV-53408 in adults with celiac disease. The expected trial duration per participant is approximately 86 weeks.
Sponsor: Teva Branded Pharmaceutical Products R&D LLC
Check if you qualify for this celiac disease clinical trial in Colorado Springs, CO
If you're searching for celiac disease treatment options in Colorado Springs, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Colorado Springs research site is actively enrolling participants for this clinical trial. You'll receive care from experienced celiac disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.